Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study

This publication has 40 references indexed in Scilit:

• Modulation of Proteasomal Activity Required for the Generation of a Cytotoxic T Lymphocyte–defined Peptide Derived from the Tumor Antigen MAGE-3
  The Journal of Experimental Medicine, 1999
• Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5‐Aza‐2′‐deoxycytidine
  Japanese Journal of Cancer Research, 1996
• The graft-versus-leukemla effect
  Current Opinion in Oncology, 1996
• Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis
  The Lancet, 1995
• A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3
  European Journal of Immunology, 1994
• Structure, chromosomal localization, and expression of 12 genes of the MAGE family
  Immunogenetics, 1994
• A tumour‐associated antigen expression in human haematological malignancies
  British Journal of Haematology, 1993
• A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
  The Journal of Experimental Medicine, 1992
• A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
  Science, 1991
• Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts
  New England Journal of Medicine, 1979